14 November, 2018

Synthetic DNA-delivered antibodies protect against Ebola in preclinical studies. Scientists successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) that offer complete and long-term protection against lethal virus challenges in a mouse model, as reported in Cell Reports.


No comments: